中文EN
Proteomics Platform
蛋白组学平台
R&D–Production–Service integrated mass spectrometry pipeline

Team experience: 30+ years of clinical protein mass spectrometry

100+ proprietary IPs covering sample processing, data analysis and clinical interpretation

Development and clinical translation of protein biomarkers

  • Multi-omics Integrated Diagnosis
    Mass spectrometry-based protein detection and diagnostic services that complement the genomics platform
  • Database Services
    Collecting disease-specific proteomics big data to serve precision medicine
  • Targeted Drug Selection
    Quantitative detection of thousands of tumor markers, providing a new basis for drug selection
  • CRO Services
    Mass spectrometry-based disease biomarker discovery and translational outsourcing services

Thermo Fisher's Q-Exactive HF mass spectrometry platform, complemented by multiple LC-MS systems from Waters, Dionex and Shimadzu. The advanced quadrupole technology (AQT) within the system improves precursor ion selection and transmission, enabling more accurate quantification of low-abundance analytes in complex clinical sample matrices. The sophisticated data-independent acquisition (DIA) and parallel reaction monitoring (PRM) techniques deliver the qualitative confidence and quantitative reproducibility required for clinical services, supporting a wide range of quantitative proteomics services including TMT, label-free, DIA and PRM.


Proteint collaborates with its allied company Immune Tech (USA) on antibody development for protein biomarkers, translating mass spectrometry research into clinical applications in the form of ELISA kits and Luminex bead-based kits.


platform.png

Copyright © ProteinT (Tianjin) Biotechnology Co., Ltd. All rights reserved. Support by Unite talent
津ICP备17007797号-1